| __timestamp | ACADIA Pharmaceuticals Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 9136000 |
| Thursday, January 1, 2015 | 76369000 | 5807000 |
| Friday, January 1, 2016 | 4406000 | 5571000 |
| Sunday, January 1, 2017 | 13060000 | 5366000 |
| Monday, January 1, 2018 | 18330000 | 6337000 |
| Tuesday, January 1, 2019 | 19598000 | 11347000 |
| Wednesday, January 1, 2020 | 20550000 | 30419000 |
| Friday, January 1, 2021 | 19141000 | 62176000 |
| Saturday, January 1, 2022 | 10166000 | 52827000 |
| Sunday, January 1, 2023 | 45731000 | 35049000 |
Unleashing insights
In the competitive world of pharmaceuticals, understanding cost dynamics is crucial. ACADIA Pharmaceuticals Inc. and Ligand Pharmaceuticals Incorporated, two prominent players, have shown intriguing trends in their cost of revenue from 2014 to 2023. ACADIA's cost of revenue peaked in 2015, reaching nearly 76% higher than its 2014 value, before experiencing fluctuations. By 2023, it saw a resurgence, increasing by approximately 350% from its 2016 low. Meanwhile, Ligand Pharmaceuticals displayed a more consistent upward trajectory, with a notable spike in 2021, marking a 1,000% increase from 2014. This data highlights the strategic shifts and market pressures faced by these companies over the years. As the pharmaceutical landscape evolves, monitoring such financial metrics becomes essential for investors and industry analysts alike.
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Grifols, S.A. vs ACADIA Pharmaceuticals Inc.
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Ligand Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost of Revenue: Key Insights for Alkermes plc and Ligand Pharmaceuticals Incorporated
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored